ASR Vermogensbeheer N.V. Takes Position in Cardinal Health, Inc. (NYSE:CAH)

Key Points

• ASR Vermogensbeheer N.V. has acquired a new position in Cardinal Health, Inc., purchasing 55,102 shares valued at approximately $7.59 million in the first quarter.
• Institutional investors and hedge funds collectively own 87.17% of Cardinal Health's stock, with several firms recently increasing their stakes significantly.
• Analysts have upgraded Cardinal Health's target price, with some setting new price targets ranging from $160.00 to $179.00, reflecting a generally positive outlook on the stock.

ASR Vermogensbeheer N.V. acquired a new stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 55,102 shares of the company's stock, valued at approximately $7,592,000.

A number of other institutional investors have also recently made changes to their positions in CAH. Greykasell Wealth Strategies Inc. bought a new position in shares of Cardinal Health during the first quarter valued at approximately $26,000. Bellwether Advisors LLC bought a new position in Cardinal Health in the fourth quarter worth $32,000. Tompkins Financial Corp raised its holdings in Cardinal Health by 106.7% in the first quarter. Tompkins Financial Corp now owns 248 shares of the company's stock worth $34,000 after purchasing an additional 128 shares in the last quarter. Itau Unibanco Holding S.A. bought a new position in shares of Cardinal Health during the fourth quarter valued at $36,000. Finally, GW&K Investment Management LLC increased its holdings in shares of Cardinal Health by 113.4% during the first quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock valued at $37,000 after acquiring an additional 144 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Stock Up 0.9%

NYSE:CAH traded up $1.38 on Monday, hitting $158.79. The stock had a trading volume of 629,793 shares, compared to its average volume of 2,358,205. Cardinal Health, Inc. has a 52-week low of $100.07 and a 52-week high of $168.44. The stock has a market cap of $37.90 billion, a price-to-earnings ratio of 24.76, a price-to-earnings-growth ratio of 1.56 and a beta of 0.67. The business's 50-day simple moving average is $160.05 and its two-hundred day simple moving average is $143.96.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on CAH shares. Evercore ISI restated an "outperform" rating and set a $180.00 price target (up from $175.00) on shares of Cardinal Health in a report on Thursday, June 12th. Citigroup restated a "neutral" rating and set a $170.00 price target (up from $157.00) on shares of Cardinal Health in a report on Friday, June 13th. Morgan Stanley raised their price target on Cardinal Health from $181.00 to $190.00 and gave the company an "overweight" rating in a report on Wednesday, July 16th. UBS Group increased their price objective on Cardinal Health from $150.00 to $160.00 and gave the company a "buy" rating in a research report on Tuesday, April 29th. Finally, Bank of America increased their price objective on Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research report on Tuesday, June 10th. Three investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, Cardinal Health presently has an average rating of "Moderate Buy" and an average target price of $158.07.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.